Maintenance chemotherapy for ovarian cancer (Q24235427)

2

0 references

Dong Mei Wei

3

0 references

Fang Fang

4

0 references

Guan J Liu

5

0 references

Huan Yu Xie

6

0 references

Xun Wang

7

0 references

Juan Zou

8

0 references

Xu Han

9

0 references

Dan Feng

Cochrane Database of Systematic Reviews

10

0 references

publication date

8 September 2010

0 references

published in

0 references

cites work

Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

A Randomized Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Complete Remission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Treatment options in the management of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Challenges for chemotherapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

Ovarian cancer treatment: what is new.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

First-line treatment regimens and the role of consolidation therapy in advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

First-line therapy for ovarian carcinoma: what's next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

7 January 2021

inferred from DOI database lookup

Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatme

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

7 January 2021

inferred from DOI database lookup

Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007414.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD007414.PUB2

0 references

Fatcat ID

release_c6cmhxzf3zgshatvb2wmqpkqii

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c6cmhxzf3zgshatvb2wmqpkqii

24 November 2022